Dr Cyriac Abby Philips, a hepatologist based in Kochi, India, has become one of the country's most polarizing medical voices by challenging traditional medicine practices on social media. His blunt online criticism of Ayurveda and homeopathy practitioners has earned him millions of followers while simultaneously generating intense backlash from India's traditional medicine establishment.
Philips built his platform by posting evidence-based critiques of unproven remedies, particularly those marketed for liver disease. His direct approach resonates with audiences seeking science-backed health information. He has documented cases where patients delayed conventional treatment while using traditional remedies, sometimes with serious consequences for their liver health.
The friction intensifies because India's traditional medicine systems hold deep cultural roots and government support. Ayurveda and homeopathy remain widely practiced and funded by state health programs, creating a collision between Western-trained medical science and centuries-old practices. Philips refuses to acknowledge any validity in treatments lacking rigorous clinical evidence, a stance that practitioners in traditional medicine view as dismissive of their disciplines.
His opponents argue that Philips oversimplifies complex systems and ignores traditional medicine's philosophical foundations. Some accuse him of using his platform to delegitimize practices that millions of Indians trust. Traditional medicine organizations have filed complaints against him, though these have not resulted in formal sanctions.
Philips maintains that patient safety demands uncompromising honesty about which treatments work. He continues documenting cases of liver damage linked to unverified remedies, posting educational content about hepatitis and cirrhosis prevention.
The clash reflects a broader global tension: how healthcare systems integrate traditional practices with evidence-based medicine. India's situation remains particularly acute because both systems operate simultaneously with government backing, creating confusion for patients trying to navigate treatment options.
Philips' prominence demonstrates that younger Indians increasingly seek scientific validation for medical